Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹4,731.40
141.30 (3.08%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹21.65K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
29.1
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹4,360.1+8.5%
52W High₹5,873.5-19.4%
Current Price
₹4,731.40
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹3,785.12
Upper Circuit₹5,677.68
Reference Price
₹4,731.40
Investment Checklist
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹5019.5
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹4695.7
10/20 Bullish Cross detected 1 day(s) ago
EMA(50) Crossover: Price crossed above EMA(50): Fresh bullish momentum signal.
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
46%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bearish MA stack (20<50<200)
EMA20
4546.46
EMA50
4597.33
EMA200
4857.94
Price Action
UPTREND
BULLISH
Higher Highs7
Higher Lows7
Lower Highs2
Lower Lows2
Support & Resistance Levels
Resistance (Above)
₹4734.53
₹4925.64
₹5105.79
₹5281.25
₹5441.00
Support (Below)
₹4616.56
₹4521.50
₹4460.00
₹4378.40
Volume Analysis
TrendINCREASING
Change+64.80%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bullish Cross
1 day ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹4684.09
3% Risk₹4589.46
5% Risk₹4494.83
7% Risk (Custom)
₹4400.20Technical Levels
1x ATR (Volatility)₹4626.28
2x ATR (Swing)₹4521.16
3x ATR (Trend)₹4416.04
Immediate Support₹4616.56
Moving Averages
EMA 9 (Short-term)₹4570.80
EMA 20 (Medium-term)₹4546.46
EMA 50 (Trend)₹4597.33
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹591.6 Cr | ₹603.1 Cr | ₹642.3 Cr | ₹645 Cr |
| Net Profit | ₹330.9 Cr | ₹191.8 Cr | ₹189 Cr | ₹141.8 Cr |
| EPS | — | ₹41.91 | ₹41.32 | ₹31.01 |
| Operating Profit | ₹444.9 Cr | ₹277.2 Cr | ₹271.8 Cr | ₹208.2 Cr |
ROE
18.20%
ROCE
23.68%
Debt/Equity
0.03
Current Ratio
6.17
OPM
32.28%
NPM
21.99%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Pfizer Limited | ₹4,731.40 | +3.08% | 29.1 | ₹21.65K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 09 Jul 2025 | Dividend - Rs 35 Per Share & Special Dividend Of Rs 100 Per Share/ Special Dividend Of Rs 30 | SPECIAL_DIVIDEND |
| 21 Aug 2024 | Dividend - Rs 35 Per Share | DIVIDEND |
| 11 Aug 2023 | Dividend - Rs 35 Per Share/ Special Dividend - Rs 5 Per Share | SPECIAL_DIVIDEND |
| 19 Sept 2022 | Special Dividend - Rs 30 Per Share | SPECIAL_DIVIDEND |
| 18 Aug 2022 | Dividend - Rs 35 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for PFIZER
View All
positive
CNBC TV18 - Markets 33d ago
Here is the one sector bucking the trend in a weak market; Check out top gainers
Five among the top 10 gainers on the Nifty 500 index are Pharma stocks. They include Pfizer (Up 4.6%), Anthem Biosciences (Up 2.5%), Syngene (Up 2%), Aster DM Healthcare (Up 2%) and Wockhardt (Up 2%).
ANTHEMAONELIQUIDAONENIFTYAONETMMQ50AONETOTALASTERDMBANKIETFESGGROWWLOVOLGROWWMOM50HCGHCG-REHEALTHADDHEALTHAXISHEALTHCAREHEALTHIETFHEALTHYMASPTOP50MOCAPITALMOMENTUM50MONIFTY500MOSERVICEMULTICAPPFIZERPHARMABEESPVTBANIETFSDL26BEESSYNGENETOP10ADDTOP15IETFTOP20VALUEWOCKPHARMAFinancial ServicesHealthcare
neutral
ET Markets - Industry 58d ago
From oncology to obesity, Pfizer bets big on India for its next growth wave
Pfizer is focusing on India for future growth. The company plans to launch new medicines quickly and at affordable prices. India is seen as a crucial market for new treatments in cancer, obesity, and vaccines. Pfizer is also working on local clinical studies for future drug launches.
AFFORDABLEFELFELDVRFMNLPFIZERCapital GoodsConsumer Services
NEWS
positive
Business Standard - Markets 59d ago
Pfizer standalone net profit declines 39.62% in the March 2026 quarter
Sales rise 6.31% to Rs 629.23 crore
PFIZERHealthcare